Product: Hib Vaccine Liquid Solution: Single Dose Vial. This potent immunization agent comprises of a purified, non-infectious subunit of Haemophilus influenzae type b (Hib) bonded to a diphtheria toxin mutant, CRM 197.
Designed to combat the global threat of Haemophilus influenzae type b (Hib) disease, our Hib Vaccine plays a crucial role in children's health. Hib, a bacterium, triggers severe illnesses, notably pneumonia and meningitis, particularly in children under 5 years old.
Every 0.5ml dose is meticulously prepared from Hib bacteria cultured in a chemically defined medium. Harvested and purified via a high-tech ultrafiltration process, the final vaccine represents a chemically purified, non-infectious Hib capsular polysaccharide, that is covalently linked to CrossReacting Material 197 (CRM 197), a harmless diphtheria toxin mutant that acts as a carrier protein. Each vial keeps freshness with 0.05mg thiomersal.
The Hib Vaccine is designed for intramuscular injection into the anterolateral aspect of the thigh for infants and the deltoid muscle as the preferred site for older children and adults.
Our Hib Vaccine, paramount to preventing Hib diseases, is an asset in maintaining global child health. Adhering to the right vaccination timeline can play an instrumental role in mitigating severe health risks.